Finbar Larkin - Jazz Pharmaceuticals VP Operations
| J7Z Stock | EUR 116.85 1.15 0.97% |
Insider
Finbar Larkin is VP Operations of Jazz Pharmaceuticals plc
| Age | 65 |
| Phone | 353 1 634 7800 |
| Web | https://www.jazzpharma.com |
Jazz Pharmaceuticals Management Efficiency
The company has return on total asset (ROA) of 0.053 % which means that it generated a profit of $0.053 on every $100 spent on assets. This is way below average. Jazz Pharmaceuticals' management efficiency ratios could be used to measure how well Jazz Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| BS BS | CSL Limited | 61 | |
| Thomas Laubert | Mercedes Benz Group AG | 50 | |
| Stuart BSc | Vertex Pharmaceuticals Incorpor | 57 | |
| Robert Langer | Moderna | 73 | |
| Martin Lange | Novo Nordisk AS | 53 | |
| Jeffrey MD | Vertex Pharmaceuticals Incorpor | 67 | |
| Markus Schafer | Mercedes Benz Group AG | 58 | |
| Lars Jorgensen | Novo Nordisk AS | 57 | |
| Sierk Poetting | BioNTech SE | 50 | |
| Mark Dehring | CSL Limited | N/A | |
| Shannon Klinger | Moderna | 52 | |
| Tal Zaks | Moderna | 53 | |
| Michael Boehler | BioNTech SE | N/A | |
| Jemimah Brennan | CSL Limited | N/A | |
| Marcello Damiani | Moderna | 49 | |
| Sabine Kohleisen | Mercedes Benz Group AG | 59 | |
| Israel Ruiz | Moderna | 47 | |
| Hubertus Troska | Mercedes Benz Group AG | 63 | |
| James Mock | Moderna | 46 | |
| Lavina CFA | Moderna | N/A | |
| Marcus Schindler | Novo Nordisk AS | 57 | |
Management Performance
| Return On Equity | -0.0056 | |||
| Return On Asset | 0.053 |
Jazz Pharmaceuticals plc Leadership Team
Elected by the shareholders, the Jazz Pharmaceuticals' board of directors comprises two types of representatives: Jazz Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Jazz. The board's role is to monitor Jazz Pharmaceuticals' management team and ensure that shareholders' interests are well served. Jazz Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Jazz Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Robert MD, Ex RD | ||
| Finbar Larkin, VP Operations | ||
| George Eliades, Sr Officer | ||
| Daniel Swisher, President COO | ||
| Patricia Carr, VP Officer | ||
| Heidi Manna, VP Officer | ||
| Neena JD, Ex Officer | ||
| Renee Gala, Ex CFO | ||
| Andrea Flynn, VP Relations | ||
| Bruce Cozadd, Chairman of the Board, CEO |
Jazz Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Jazz Pharmaceuticals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0056 | |||
| Return On Asset | 0.053 | |||
| Profit Margin | (0.01) % | |||
| Operating Margin | 0.27 % | |||
| Current Valuation | 13.72 B | |||
| Shares Outstanding | 62.97 M | |||
| Shares Owned By Insiders | 2.52 % | |||
| Shares Owned By Institutions | 93.17 % | |||
| Price To Earning | 15.29 X | |||
| Price To Book | 3.49 X |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Jazz Stock
When determining whether Jazz Pharmaceuticals plc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Jazz Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Jazz Pharmaceuticals Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Jazz Pharmaceuticals Plc Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Jazz Pharmaceuticals plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.